Linked Life Data

21410696

Source:http://linkedlifedata.com/resource/pubmed/id/21410696

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-17
pubmed:abstractText
Reliable measurement of disease progression and the effect of therapeutic interventions in Duchenne muscular dystrophy (DMD) require clinically meaningful and scientifically sound rating scales. Therefore, we need robust evidence to support such tools. The North Star Ambulatory Assessment (NSAA) is a promising, clinician-rated scale with potential uses spanning clinical practice and clinical trials. In this study, we used Rasch analysis to test its suitability in these roles as a measurement instrument.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1469-8749
pubmed:author
pubmed:copyrightInfo
© The Authors. Developmental Medicine & Child Neurology © 2011 Mac Keith Press.
pubmed:issnType
Electronic
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
535-42
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
pubmed:affiliation
Institute of Human Genetics, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK. anna.mayhew@ncl.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't